pMT3 p38 Citations (11)
Originally described in: Kyriakis lab plasmidsUnpublished
Articles Citing pMT3 p38
| Articles |
|---|
| p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta. Bikkavilli RK, Feigin ME, Malbon CC. J Cell Sci. 2008 Nov 1;121(Pt 21):3598-607. doi: 10.1242/jcs.032854. PubMed |
| Acetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytes. Pillai VB, Sundaresan NR, Samant SA, Wolfgeher D, Trivedi CM, Gupta MP. Mol Cell Biol. 2011 Jun;31(11):2349-63. doi: 10.1128/MCB.01205-10. Epub 2011 Mar 28. PubMed |
| A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion. Rao VH, Kandel A, Lynch D, Pena Z, Marwaha N, Deng C, Watson P, Hansen LA. Oncogene. 2012 Jun 7;31(23):2888-98. doi: 10.1038/onc.2011.460. Epub 2011 Oct 10. PubMed |
| IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. Napione L, Strasly M, Meda C, Mitola S, Alvaro M, Doronzo G, Marchio S, Giraudo E, Primo L, Arese M, Bussolino F. Angiogenesis. 2012 Dec;15(4):713-25. doi: 10.1007/s10456-012-9286-9. Epub 2012 Jul 15. PubMed |
| Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration. Czaplinska D, Turczyk L, Grudowska A, Mieszkowska M, Lipinska AD, Skladanowski AC, Zaczek AJ, Romanska HM, Sadej R. Biochim Biophys Acta. 2014 Nov;1843(11):2461-70. doi: 10.1016/j.bbamcr.2014.06.022. Epub 2014 Jul 8. PubMed |
| Tomentodione M sensitizes multidrug resistant cancer cells by decreasing P-glycoprotein via inhibition of p38 MAPK signaling. Zhou XW, Xia YZ, Zhang YL, Luo JG, Han C, Zhang H, Zhang C, Yang L, Kong LY. Oncotarget. 2017 Oct 19;8(60):101965-101983. doi: 10.18632/oncotarget.21949. eCollection 2017 Nov 24. PubMed |
| Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T alpha-synuclein model of Parkinson's disease. Chen J, Ren Y, Gui C, Zhao M, Wu X, Mao K, Li W, Zou F. Cell Death Dis. 2018 Jun 13;9(6):700. doi: 10.1038/s41419-018-0722-7. PubMed |
| DDX3 Participates in Translational Control of Inflammation Induced by Infections and Injuries. Ku YC, Lai MH, Lo CC, Cheng YC, Qiu JT, Tarn WY, Lai MC. Mol Cell Biol. 2018 Dec 11;39(1). pii: MCB.00285-18. doi: 10.1128/MCB.00285-18. Print 2019 Jan 1. PubMed |
| p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T alpha-synuclein model of Parkinson's disease. Gui C, Ren Y, Chen J, Wu X, Mao K, Li H, Yu H, Zou F, Li W. Toxicol Appl Pharmacol. 2020 Feb 1;388:114874. doi: 10.1016/j.taap.2019.114874. Epub 2019 Dec 24. PubMed |
| p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease. Chen J, Mao K, Yu H, Wen Y, She H, Zhang H, Liu L, Li M, Li W, Zou F. J Neuroinflammation. 2021 Dec 20;18(1):295. doi: 10.1186/s12974-021-02349-y. PubMed |
| p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer. Zarczynska I, Gorska-Arcisz M, Cortez AJ, Kujawa KA, Wilk AM, Skladanowski AC, Stanczak A, Skupinska M, Wieczorek M, Lisowska KM, Sadej R, Kitowska K. Cells. 2021 Nov 30;10(12). pii: cells10123363. doi: 10.3390/cells10123363. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.